Effects of kojic acid on oxidative damage and on iron and trace element level in iron-overloaded mice and rats

Central European Journal of Public Health

Volumn 12, Issue SUPPL., 2004, Pages

  Kotyzova D ^a   Eybl, V ^a   Koutensky J ^a   Brtko, J ^b   Glattre, E ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Chelator; Iron accumulation; Kojic acid; Oxidative damage; Trace elements

Indexed keywords

DEFEROXAMINE MESYLATE; GLUTATHIONE PEROXIDASE; IRON; IRON SACCHARATE; KOJIC ACID; TRACE ELEMENT; TRANSITION ELEMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IRON BLOOD LEVEL; IRON CHELATION; IRON KINETICS; IRON OVERLOAD; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; RAT;

ADMINISTRATION, ORAL; ANIMALS; DEFEROXAMINE; IRON CHELATING AGENTS; IRON OVERLOAD; LIPID PEROXIDATION; LIVER; MALE; MICE; PYRONES; RATS; RATS, WISTAR;

EID: 2342642127     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Burdock GA, Soni MG, Carabin IG: Evaluation of health aspects of kojic acid in food. Regul Toxicol Pharmacol 2001; 33: 80-101.
2. Uher M, Chalabala M, Čižmárik J: Potential use of the kojic acid and its derivatives in treatment. Čes Slov Farm 2000; 49: 288-298. (In Czech.)
3. Tamura T, Mitsumori K, Onodera H, Fujimoto N, Yasuhara K, Takegawa K, Takahashi M: Inhibition of thyroid iodine uptake and organification in rats treated with kojic acid. Toxicol Sci 1999; 47: 170-175.
4. Tamura T, Mitsumori K, Onodera J, Fujimoto N, Yasuhara K, Takegawa K, Takagi H, Hirose M: Dose-treshold for thyroid tumor-promoting effects of orally administered kojic acid in rats after initiation with N-bis(2-hydroxypropyl) nitrosamin. J Toxicol Sci 2001; 26: 85-94.
5. Fujimoto N, Onodera H, Mitsumori K, Tamura T, Maruyama S, Ito A: Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats. Carcinogenesis 1999; 20: 1567-1571
6. Molenda JJ, Basinger MA, Hanusa TP, Jones MM: Synthesis and iron (III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid. J Inorg Biochem 1994; 55: 131-46.
7. Novotný L, Rauko P, Abdel-Hamid M, Vachalková A: Kojic acid - a new leading molecule for a preparation of compounds with an antineoplastic potential. Neoplasma 1999; 46: 89-92.
8. Niwa Y, Akamatsu H: Kojic acid scavenges free radicals while potentiating leukocyte function including free radical generation. Inflammation 1991; 5: 303-315.
9. Mitani K, Koshiishi I, Sumita T, Imanari P. Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol 2001; 411: 169-174.
10. Uichima K, Mihara M: Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Analyt Biochem 1978; 86: 217-278.
11. Sedlak J, Lindsay RH: Estimation of total, proteinbound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Analyt Biochem 1968; 25: 192-205.
12. Günzler VA, Kremers H, Flohé L: An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9.) in blood. Z Klin Chem Biochem 1974; 12: 444-448.
13. Aebl H: Catalase. In: Methods of Enzymatic Analysis, vol 2, 1972 (H.U. Bergmeyer, ed.), New York & London, Academic Press, 673-684
14. Katoh S, Toyama J, Kodama I, Kamiya K, Akita T, Abe T: Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts. Eur Surg Res 1992; 24: 349-355.
15. van der Kraaij AM, van Eijk HG, Koster JF: Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol. Circulation 1989; 80: 158-164.